Clinical trials

Join our clinical trials.

Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes (FENDEEP)

Institution

Hospital Ruber Internacional & Zogenix, Inc.

Inclusion Criteria:

• Age between 2 and 35 years • Diagnosis of epilepsy associated with some degree of intellectual disability, starting before 11 years of age • All patients will have a phenotype consistent with their genetic, electroclinical or neuroimaging diagnosis

Exclusion Criteria:

How to sign up:

Contact: Ana Rodriguez +0034913875250 ensayosepi@neurologiaclinica.es

PACIFIC Developmental and Epileptic Encephalopathies Study - SYNGAP1

Institution

Longboard Pharmaceuticals

Inclusion Criteria:

• SYNGAP1 diagnosis • 12 to 65 years of age • Located near study sites in US and Australia • On stable dose of 1-4 anti-seizure meds • At least 4 motor seizures a month

Exclusion Criteria:

How to sign up:

https://pacific.researchstudytrial.com/

Skyway Study

Institution

Takeda

Inclusion Criteria:

• Has been diagnosed with Lennox-Gastaut syndrome • 2 to 55 years of age • Has had 8 or more major motor drop (MMD) seizures each month, for the past 3 months prior to screening • Has been unable to control seizures with at least 1 anti-seizure medication in the past. Video: https://vimeo.com/772487617/1fcfff374d

Exclusion Criteria:

How to sign up:

Visit https://skyway.researchstudytrial.com/